Mukka Proteins Limited Files SEBI Regulation 74(5) Certificate for Q4 FY26
Mukka Proteins Limited filed a certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The Registrar confirmed no demat requests were processed as no shares are in physical mode. This is a routine compliance filing.
This is a standard regulatory filing confirming that there were no share dematerialization requests processed, as all shares are already in dematerialized form. It has no material impact on the company's operations or financials.
The announcement is a routine compliance filing regarding share dematerialization and does not contain any material financial or operational information that would impact the company's sentiment.
Mukka Proteins Limited has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. The certificate was received from Cameo Corporate Services Limited, the company's Registrar and Share Transfer Agent.
Cameo Corporate Services Limited confirmed that no demat requests were received for processing during the quarter ending March 31, 2026. This is due to the fact that no shares of Mukka Proteins Limited are held in physical mode. The company has submitted this information to the National Stock Exchange of India Limited and BSE Limited for their records and further dissemination.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.